Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
evolocumab (repatha) (1 trial)
nevulose (1 trial)
phytosterol (1 trial)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Trials (3 total)
Trial APIs (3 total)